Spreewaelder Arzneimittel

What Spreewaelder Arzneimittel does

Spreewälder Arzneimittel GmbH is a German pharmaceutical manufacturer established in 1949, operating from a single site in Märkische Heide (Gröditsch) in the Spreewald biosphere region near Berlin. The company manufactures medicinal products, medical devices, cosmetics, and dietary supplements in GMP-compliant facilities, with production capabilities spanning liquids, semi-solids (creams, ointments, gels), and solid dosage forms (tablets, hard gelatin capsules, suppositories/ovules) at industrial scale (mixers up to 1000L for liquids/semi-solids and 200L for solids). Its proprietary consumer product portfolio centers on three registered brands: Mediderm® — a cortisone-, SLS-, paraben-, and fragrance-free dermatological series (cream, shampoo, shower emulsion) for psoriasis, eczema, and atopic dermatitis; Retimax 1500 — a vitamin A (1500 IU/g retinyl palmitate) anti-aging ointment; and Cerutalgin SPRAY — a medical device for earwax removal with cited clinical survey outcomes.

The firm operates a dual business model. On the consumer side, it sells its own branded products directly via links to a third-party online pharmacy marketplace (doc.green), targeting German and international consumers seeking cortisone-free dermatological care and ear hygiene solutions. On the B2B side, it provides contract manufacturing (toll manufacturing) services — including weighing, mixing, homogenization, filling, packaging, serialization, tamper-evident labelling, in-house quality control, stability testing, and 24-hour delivery — to pharmaceutical companies, dietary supplement manufacturers, dietary food producers, and cosmetics brands seeking GMP-compliant production capacity in Germany and Europe. Pricing for consumer products is handled by the pharmacy platform and not publicly disclosed; contract manufacturing is quote-based. The company is a subsidiary of the FARMINA Group, a Polish pharmaceutical conglomerate, with Adam Swiderski serving as the legal representative.

Name

Spreewaelder Arzneimittel

Legal name

Spreewälder Arzneimittel GmbH

Website

https://spreewaelder-arzneimittel.de

Company type

Private

Founded year

1949

Operating status

Operating

Headcount range

11–50 employees

Short description

Spreewälder Arzneimittel GmbH is a German GMP-compliant pharmaceutical manufacturer (founded 1949) producing proprietary dermatological, vitamin A, and ear-care consumer brands, alongside contract manufacturing services for pharmaceutical, supplement, and cosmetics clients in Germany and Europe.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Topical & Dermatology Generics (HLAIABAE)

Keywords

• Pharmaceutical manufacturing
• Dermatological products
• Contract manufacturing
• Medical devices
• OTC healthcare products

Headquarters

HQ city

Marktschellenberg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Proprietary Product Sales: Sale of own-branded pharmaceutical and cosmetic products including Mediderm® series, Retimax 1500, and Cerutalgin spray through direct online ordering channels.
2. Contract Manufacturing Services: Toll manufacturing services for pharmaceutical products, dietary supplements, dietary foods for special medical purposes, and cosmetics. Services include production (liquids, semi-solids, solids), serialization, quality control laboratory services, and storage/delivery of finished products. All production stages comply with GMP guidelines.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

Spreewälder Arzneimittel GmbH manufactures and sells proprietary pharmaceutical products—including the Mediderm® dermatological series, Retimax 1500 vitamin A ointment, and Cerutalgin earwax removal spray—and provides GMP-compliant contract manufacturing services for pharmaceuticals, dietary supplements, dietary foods for special medical purposes, and cosmetics. Products include liquids, semi-solids (creams, ointments, gels), and solid dosage forms (tablets, hard gelatin capsules, suppositories), with in-house quality control laboratory testing and serialization.

Product overview

Spreewälder Arzneimittel is a traditional pharmaceutical company established in 1949, offering a portfolio of three proprietary product lines—Mediderm® (a comprehensive dermatological therapy series for psoriasis, eczema, and atopic dermatitis in multiple formats including cream, shampoo, and shower emulsion), Retimax 1500 (a vitamin A anti-aging ointment), and Cerutalgin SPRAY (a medical device for earwax removal)—alongside contract manufacturing services for pharmaceuticals, dietary supplements, medical foods, and cosmetics. The company operates GMP-compliant production facilities in the Spreewald region near Berlin.

Differentiator

Problem solved

Functional benefit

Brands

• Mediderm®: Product series for treatment of psoriasis, eczema, atopic dermatitis and extreme dry skin conditions. Products contain no SLS, parabens, fragrances or artificial colours.
• Retimax 1500
• Cerutalgin

Products and services

• Mediderm® Series Comprehensive dermatological therapy series for pathological dry skin conditions including psoriasis, eczema, and atopic dermatitis. Includes cream (100g, 500g, 1kg), shampoo (200g), and shower emulsion (250g) formats. Products are free from cortisone, SLS, parabens, fragrances, and artificial colours, with rapid absorption that does not stain clothing or bedding.
• Retimax 1500 Vitamin A ointment containing 1500 IU (International Units) of retinol as retinyl palmitate per gram of ointment. Stimulates cell renewal, intensifies collagen production, and promotes blood vessel formation. Recommended for anti-aging care of the delicate skin under the eyes.
• Cerutalgin SPRAY Medical device for removal of earwax from the external auditory canal; supports ear hygiene and helps prevent formation of earwax plugs. Comes with a special applicator for convenient dosing. Clinical survey data shows 92% of users experienced improvement in ear canal secretion reduction and 84% reported improved hearing.
• Contract Manufacturing Services (Lohnfertigung / Lohnherstellung) GMP-compliant contract manufacturing service for pharmaceuticals, dietary supplements, dietary foods for special medical purposes, and cosmetics. Production covers liquids and semi-solids (creams, ointments, gels) at 250L, 500L, and 1000L mixing capacity, and solids (tablets, hard gelatin capsules, suppositories/ovules) at 100L and 200L capacity. Includes weighing, mixing, heating, homogenization, filling, packaging, serialization, tamper-evident labelling, in-house QC analyses, stability testing, storage, order processing, and 24-hour delivery of finished products. Targeted at pharmaceutical, dietary supplement, and cosmetics companies in Germany and abroad.

Quantifiable outcome

• 92% of surveyed users experienced improvement in ear canal secretion reduction with Cerutalgin spray
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• FARMINA Group (Farmina Group)coreOthersSpreewälder Arzneimittel GmbH is identified as a company of the FARMINA Group (www.farmina.pl). This indicates a parent company or corporate group relationship where Spreewälder Arzneimittel operates under the FARMINA Group umbrella.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Dr. Wolff Group: German family-owned pharma/cosmetics company with skincare brands including Linola (dermatology) and Alpecin. Directly comparable in combining dermatology/OTC product lines with cosmetics-grade consumer brands and German market orientation.
• Dermapharm Holding AG: German branded pharmaceutical manufacturer focused on dermatology, allergy, and OTC products. Closely comparable to Spreewälder in product mix (topical dermatology, OTC brands) and German market focus, but at substantially greater scale and with public-market financing.
• Aenova Group: One of the largest German pharmaceutical contract manufacturers (CMO/CDMO) covering solids, semi-solids, and liquids under GMP. Directly comparable to Spreewälder's contract/toll manufacturing business with broader scale.
• Engelhard Arzneimittel GmbH & Co. KG: German mid-sized OTC pharmaceutical manufacturer with a portfolio in dermatology, cough/cold, and natural health. Comparable to Spreewälder as a similarly-sized German OTC pharma company with a branded proprietary portfolio.
• Strathmann GmbH & Co. KG: German OTC pharmaceutical manufacturer focused on women's health, dermatology, and respiratory therapeutic areas. Comparable in mid-sized German OTC pharma profile and branded proprietary product strategy.
• Rottendorf Pharma GmbH: German pharmaceutical contract manufacturer offering GMP-compliant production of solids, semi-solids, and liquids including serialization. Comparable to Spreewälder's B2B contract manufacturing services with overlapping dosage forms and quality systems.
• Heel GmbH: German pharmaceutical company focused on OTC and biological-based medicines for dermatology, musculoskeletal, and immune conditions. Closely comparable in target therapeutic categories and German/European market orientation.
• Klosterfrau GmbH: German OTC pharmaceutical and personal care company with a heritage brand portfolio spanning dermatology, gastrointestinal, and cosmetics. Comparable in combining legacy OTC brands with personal-care/cosmetic positioning targeting German consumers.
• STADA Arzneimittel AG: Major German generics and OTC pharmaceutical company with broad dermatology, ENT, and consumer healthcare brands. Comparable as a direct competitor in the German OTC and proprietary-branded dermatology space where Spreewälder competes.

Broad incumbents

• Merz Pharma GmbH & Co. KGaA: German specialty pharmaceutical company with broad prescription, OTC, and aesthetics/dermatology offerings. Comparable at the broad-incumbent level given its German pharma/consumer health orientation, though considerably larger and more diversified than Spreewälder.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Spreewaelder Arzneimittel